| 일자 | 시간 | 출처 | 헤드라인 | 심볼 | 기업 |
| 2018/12/07 | 07:10 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 2018/12/07 | 06:18 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 2018/12/05 | 07:53 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 2018/12/05 | 07:49 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 2018/11/14 | 07:02 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 2018/11/14 | 07:01 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 2018/11/14 | 07:00 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 2018/11/14 | 06:59 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 2018/11/10 | 07:09 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 2018/11/10 | 06:19 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 2018/11/10 | 06:17 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 2018/10/31 | 05:32 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 2018/10/27 | 05:59 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 2018/10/27 | 05:18 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 2018/10/25 | 06:04 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 2018/10/25 | 06:04 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 2018/10/03 | 05:57 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 2018/09/26 | 06:02 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 2018/09/26 | 06:01 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 2018/09/26 | 06:00 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 2018/09/26 | 05:59 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 2018/09/25 | 05:20 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 2018/09/19 | 05:57 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 2018/09/05 | 05:46 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 2018/08/17 | 20:01 | Edgar (US Regulatory) | Proxy Statement (definitive) (def 14a) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 2018/08/15 | 06:06 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 2018/08/15 | 06:00 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 2018/08/08 | 06:04 | Edgar (US Regulatory) | Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 2018/08/04 | 06:22 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 2018/08/04 | 05:18 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |